167 related articles for article (PubMed ID: 21819616)
1. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria.
Ong'echa JM; Raballah EO; Kempaiah PM; Anyona SB; Were T; Davenport GC; Konah S; Vulule JM; Ouma C; Hittner JB; Perkins DJ
BMC Genet; 2011 Aug; 12():69. PubMed ID: 21819616
[TBL] [Abstract][Full Text] [Related]
2. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production.
Ouma C; Davenport GC; Were T; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Hum Genet; 2008 Dec; 124(5):515-24. PubMed ID: 18972133
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.
Anyona SB; Hengartner NW; Raballah E; Ong'echa JM; Lauve N; Cheng Q; Fenimore PW; Ouma C; Lambert CG; McMahon BH; Perkins DJ
J Hum Genet; 2020 Jan; 65(2):99-113. PubMed ID: 31664161
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults.
Phawong C; Ouma C; Tangteerawatana P; Thongshoob J; Were T; Mahakunkijcharoen Y; Wattanasirichaigoon D; Perkins DJ; Khusmith S
Immunogenetics; 2010 Jun; 62(6):345-56. PubMed ID: 20387064
[TBL] [Abstract][Full Text] [Related]
5. Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.
Onyango CO; Cheng Q; Munde EO; Raballah E; Anyona SB; McMahon BH; Lambert CG; Onyango PO; Schneider KA; Perkins DJ; Ouma C
BMC Genomics; 2023 Sep; 24(1):542. PubMed ID: 37704951
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
Kisia LE; Kempaiah P; Anyona SB; Munde EO; Achieng AO; Ong'echa JM; Lambert CG; Chelimo K; Ouma C; Perkins DJ; Raballah E
BMC Med Genet; 2019 Aug; 20(1):140. PubMed ID: 31420016
[TBL] [Abstract][Full Text] [Related]
7. Haplotype of non-synonymous mutations within IL-23R is associated with susceptibility to severe malaria anemia in a P. falciparum holoendemic transmission area of Kenya.
Munde EO; Raballah E; Okeyo WA; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):291. PubMed ID: 28427357
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.
Okeyo WA; Munde EO; Okumu W; Raballah E; Anyona SB; Vulule JM; Ong'echa JM; Perkins DJ; Ouma C
BMC Immunol; 2013 Mar; 14():15. PubMed ID: 23521898
[TBL] [Abstract][Full Text] [Related]
9. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
Anyona SB; Kempaiah P; Raballah E; Ouma C; Were T; Davenport GC; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
Infect Immun; 2011 Dec; 79(12):4923-32. PubMed ID: 21969001
[TBL] [Abstract][Full Text] [Related]
10. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.
Ouma C; Davenport GC; Garcia S; Kempaiah P; Chaudhary A; Were T; Anyona SB; Raballah E; Konah SN; Hittner JB; Vulule JM; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Feb; 131(2):289-99. PubMed ID: 21818580
[TBL] [Abstract][Full Text] [Related]
11. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
12. A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.
Ouma C; Keller CC; Davenport GC; Were T; Konah S; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Infect Immun; 2010 Jan; 78(1):453-60. PubMed ID: 19884328
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.
Zhang L; Prather D; Vanden Eng J; Crawford S; Kariuki S; ter Kuile F; Terlouw D; Nahlen B; Lal AA; Slutsker L; Udhayakumar V; Shi YP
Malar J; 2010 Mar; 9():87. PubMed ID: 20350312
[TBL] [Abstract][Full Text] [Related]
14. Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children.
Achieng AO; Hengartner NW; Raballah E; Cheng Q; Anyona SB; Lauve N; Guyah B; Foo-Hurwitz I; Ong'echa JM; McMahon BH; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():290-302. PubMed ID: 31278068
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.
Munde EO; Okeyo WA; Anyona SB; Raballah E; Konah S; Okumu W; Ogonda L; Vulule J; Ouma C
Infect Immun; 2012 Dec; 80(12):4435-43. PubMed ID: 23045477
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.
Ouma C; Davenport GC; Awandare GA; Keller CC; Were T; Otieno MF; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
J Infect Dis; 2008 Oct; 198(8):1219-26. PubMed ID: 18781863
[TBL] [Abstract][Full Text] [Related]
17. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia.
Keller CC; Yamo O; Ouma C; Ong'echa JM; Ounah D; Hittner JB; Vulule JM; Perkins DJ
Infect Immun; 2006 Sep; 74(9):5249-60. PubMed ID: 16926419
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area.
Novelli EM; Hittner JB; Davenport GC; Ouma C; Were T; Obaro S; Kaplan S; Ong'echa JM; Perkins DJ
Br J Haematol; 2010 Jun; 149(5):711-21. PubMed ID: 20408849
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling.
Achieng AO; Guyah B; Cheng Q; Ong'echa JM; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():278-289. PubMed ID: 31257148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
